Medindia
Medindia LOGIN REGISTER
Advertisement

Groundbreaking Study Employing Sensonics International's Products Reveals Weight Loss Medications Impair Taste Function

Friday, January 31, 2025 Weight Loss
Advertisement
PR Newswire

PHILADELPHIA, Jan. 30, 2025

PHILADELPHIA, Jan. 30, 2025 /PRNewswire/ -- A new study published in Physiology & Behavior uncovers significant sensory implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications commonly prescribed for weight loss and obesity management. Researchers at the University of Pennsylvania found that GLP-1 RAs significantly impair taste function across all five basic taste qualities: sweet, sour, salty, bitter, and umami (brothy).
Advertisement

The study, led by Dr. Rafa Khan and Dr. Richard L. Doty, employed state-of-the-art olfactory assessment tools, including the 53-item Waterless Empirical Taste Test (WETT®) and the 40-item University of Pennsylvania Smell Identification Test (UPSIT®). A sample of 46 individuals taking GLP-1 RAs was compared to 46 matched controls. Results revealed that 85% of GLP-1 RA users had significantly diminished taste perception, with an average WETT® score 29% lower than that of the control group.
Advertisement

This research demonstrates, for the first time, that GLP-1 receptor agonists negatively impact a major sensory system. The reduction in taste perception could have profound implications for dietary choices, nutrition, and overall metabolic health.

Additionally, the study noted that participants experiencing common GLP-1 RA-related side effects, such as nausea and diarrhea, showed better taste and smell function than those without these symptoms. However, smell function overall was not significantly impacted.

GLP-1 RAs, originally developed for diabetes management, have become increasingly popular for weight loss, with over 10% of the U.S. population now prescribed these medications. This study sheds light on a previously underexplored consequence of these drugs, adding a new dimension to their understanding.

View original content:https://www.prnewswire.com/news-releases/groundbreaking-study-employing-sensonics-internationals-products-reveals-weight-loss-medications-impair-taste-function-302364721.html

SOURCE Sensonics International
Sponsored Post and Backlink Submission


Latest Press Release on Weight Loss

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close